Name | 3-Benzyl-7-(1,3-oxazol-2-ylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine |
---|---|
Synonyms |
3-Benzyl-7-(1,3-oxazol-2-ylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine
3H-1,2,3-Triazolo[4,5-d]pyrimidine, 7-(2-oxazolylthio)-3-(phenylmethyl)- |
Description | VAS 3947, a specific NADPH oxidase (NOX) inhibitor, exerts a potent antiplatelet effect. VAS3947 induces apoptosis independently of anti-NOX activity, via UPR activation, mainly due to aggregation and misfolding of proteins[1][2]. |
---|---|
Related Catalog | |
In Vitro | VAS3947 consistently inhibits NADPH oxidase activity in low micromolar concentrations, and interferes neither with ROS detection nor with XOD or eNOS activities. VAS3947 (30 µM) does not interfere with xanthine/XOD-derived L012 signals, suggesting this compound is free of antioxidant or scavenging effects relevant to ROS detection. In CaCo-2 cell homogenates, VAS3947 completely blocks NADPH-dependent ROS production with an IC50 of 12 µM[1]. VAS3947 triggers cell proliferation arrest and death independently of anti-NOX activity. The IC50 values of the different cell lines ranges from 2.6 ± 0.6 µM for the most sensitive cell line MV-4-11 to 4.9 µM for THP-1, the least sensitive[2]. VAS3947 decreases ROS levels. VAS3947 triggers endoplasmic reticulum (ER) stress and consequent unfolding protein response (UPR)[2]. VAS3947 attenuates platelet activation and thrombus formation via a NOX-independent pathway downstream of PKC3]. |
In Vivo | NADPH 氧化酶抑制剂 |
References |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 577.8±60.0 °C at 760 mmHg |
Molecular Formula | C14H10N6OS |
Molecular Weight | 310.334 |
Flash Point | 303.3±32.9 °C |
Exact Mass | 310.063690 |
LogP | 1.96 |
Vapour Pressure | 0.0±1.5 mmHg at 25°C |
Index of Refraction | 1.801 |
Storage condition | 2-8°C |